Kura Oncology, Inc.KURANASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-57.16%
↓ 87% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-30.55%
Historical baseline
PeriodValue
2025-57.16%
2024-16.52%
2023-18.55%
2022-6.56%
2021-42.83%
2020-36.19%
2019-7.31%
2018-74.30%
2017-27.18%
2016-18.86%